Remove 2011 Remove FDA Remove Immunization
article thumbnail

Pharmacy Schools Should Prepare Students for Workforce Challenges

Drug Topics

Research shows that close to 30% of all US drug stores closed from 2011 to 2021, according to US News & World Report. 1 “The results of these surveys are glimpses of the national pharmacist burnout that is being observed, showing that burnout is a crucial area of focus that needs to be addressed.”

article thumbnail

BMS’ Orencia gets FDA nod for GvHD thanks to real-world data

pharmaphorum

Bristol-Myers Squibb’s rheumatoid arthritis drug Orencia has been approved by the FDA to prevent graft versus host disease (GvHD), a serious complication of haematopoietic stem cell transplant (HSCT) used to treat leukaemias and other blood cancers. billion in the first nine months of the year.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

In August 2021, Saphnelo, a type 1 interferon receptor antibody, became the first lupus treatment to be approved since GSK’s Benlyta (belimumab) won a regulatory nod in 2011. In lupus, the body’s immune system starts to attack its own cells. As per AstraZeneca's recent Q3 earnings, Saphnelo has yielded $69 million to date this year.

article thumbnail

Understanding the microbiome as an ‘overlooked critical organ’

pharmaphorum

PubMed cites 1,822 pieces of research relating to the microbiome in 2011, which grew to 25,153 published in 2021. As more research has been conducted, closer and unexpected links have been found between the microbiome of the gut, as one example, and other areas of the body, such as brain health and the immune system.

article thumbnail

Re-engineering proteins to develop novel immunotherapies

European Pharmaceutical Review

The field of immunotherapy is constantly evolving with the ultimate goal to develop new treatments that help the body’s immune system fight cancer. Immune cells, such as T cells and natural killer (NK) cells, have the inherent ability to combat diseases, including cancer, but are often inhibited by the body’s own suppressive mechanisms.

article thumbnail

BMS gets FDA OK for first LAG-3 checkpoint inhibitor

pharmaphorum

Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy including Merck & Co. Like PD-1, LAG-3 is a negative regulator of T cells, suppressing their activity against cancer cells, so when that brake is released the immune system can attack and kill tumours.

FDA 52
article thumbnail

How to stop taking omeprazole

The Checkup by Singlecare

Food and Drug Administration (FDA) to treat gastroesophageal reflux disease (GERD), duodenal ulcers, Helicobacter pylori infections ( H.Pylori ), benign gastric ulcers, erosive esophagitis, and conditions that cause excess stomach acid production (hypersecretory conditions). At prescription strengths, omeprazole is approved by the U.S.

FDA 98